Services:

Real-World Evidence

Lowering the barriers to high-impact real-world evidence.

Home / Services / Real-World Evidence

Life sciences companies strive to make real-world evidence (RWE) a routine part of their decision-making process, but face challenges optimizing their use of real-world data (RWD).

Trinity EvidenceFirst™

Trinity’s EvidenceFirst offerings deliver meaningful RWE solutions by providing an experienced partner to work alongside life sciences leaders, with the context to flexibly implement built-for-purpose insights – and to draw on the appropriate data assets, from each company’s existing array of data resources to Trinity’s unique in-house data portfolio.

The EvidenceFirst Suite of Offerings

EvidenceFirst offerings align to and can be integrated with our best-in-class research and advisory services across six Centers of Excellence.

Landscape Assessment, Early Asset, and Portfolio Strategy

Landscape Assessment, Early Asset, and Portfolio Strategy

RWE provides key market elements such as epidemiology, target specialties, and patient concentration to strengthen market understanding

Market Map and Patient Journey

Market Map and Patient Journey

A holistic patient journey that brings together the voice of the patients with real-world data to quantify leverage points and thoroughly understand the patient experience

HCP Segmentation, KOL Mapping

HCP Segmentation, KOL Mapping

Segmentations linking primary and secondary data to connect physician behavior and sizing segments using RWD to create a more robust, actionable segmentation for maximum impact

Evidence Generation and Payer Value Proposition

Evidence Generation and Payer Value Proposition

Full suite of well-rounded value propositions from evaluation, planning to communication (publications, manuscripts, posters, etc.). RWE helps quantify value and drive such scientific communication

Forecasting

Forecasting

RWD used to drive and validate assumptions (e.g., Epi, treatment rates, share, DOT, etc.)

Commercial Targeting

Commercial Targeting

RWE provides patient-level metrics (e.g., patient volume, treatment distribution, etc.) by HCP/Account to enhance targeting solutions and provides input into CRM and reporting platforms

  • Analytical Methods: Tailoring Analytics to Our Clients’ Needs

    Each EvidenceFirst core offering can be augmented with bespoke analytics aligned to our client’s unique business goals and data needs. We leverage our custom capabilities, proven methodologies and industry expertise to deliver a depth and breadth of analytics to support your nuanced studies. Our dedicated RWE team has in-depth experience with >15 common industry and government datasets enabling us to match the right tool and approach to your needs.

    Trinity applies Artificial Intelligence and Machine Learning models to achieve the following results for our life sciences clients. Examples include:

    • Patient Finding: Target the physicians seeing your target patients for conditions that are underdiagnosed, overdiagnosed, or poorly coded
    • Predicting Disease: Educate physicians to enable earlier diagnosis and intervention using risk factors and red flags
    • Drivers of Discontinuation: Empower increased adherence by predicting premature treatment discontinuation and by proactively intervening

    Our unique combination of market knowledge and analytical firepower allows us to provide practical applications of AI/ML where others falter:

    • Therapeutic Area Knowledge: Trinity’s roots in strategic advisory services enable us to be the contextual experts that Machine Learning needs to provide initial hypotheses and sanity check results.
    • Analytical Expertise: With trained statisticians and data scientists specializing in healthcare analytics, we frame our analytics to address our clients’ questions, not the other way around.
    • Strategic Insight: We don’t just tell you what the analysis shows – we tell you what it means. The end result is transparent actionable insights (not black boxes) that are tailored to our clients’ needs.
  • How are clients leveraging EvidenceFirst?
    • New Product Planning and Business Development: Provide insights into the market size and quantify key patterns within the patient population to identify who the patients are, who treats them, and how they are treated
    • Market Research and Brand Teams: Provide the understanding of the patient flow and quantify key patterns within the patient population to identify who the patients are, who treats them, and how they are being treated
    • Forecasting: Provide robust data to support model assumptions (e.g., market size, treatment rates, market share, days on therapy, etc.)
    • HEOR: Provide epidemiology and health care research utilization (HCRU) insights that support evidence-generation plans

Meet Our Real-World Evidence Experts

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.